Clinical Trial

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

Name: An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms — clinical trial record (NCT07329673)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate QbMobile's ability to collect objective data to identify specific symptom profiles in differential diagnoses (ASD, MDD, Bipolar Disorder and Anxiety Disorder) that are common with ADHD.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-07

Trial Details

NCT Number	NCT07329673
Lead Sponsor	Qbtech AB
Conditions	Bi-Polar Disorder, Autism Spectrum Disorder (ASD), Major Depression Disorders, Separation Anxiety Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder (GAD)
Enrollment	300 participants
Start Date	2026-01-01
Primary Completion	2026-11 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2026-05-06